CCI4EU - Bringing research insights into clinical implementation

Recordings from CCI4EU 1st Capacity Buiding Conference

CCI4EU - Bringing research insights into clinical implementation

Recordings from CCI4EU 1st Capacity Buiding Conference


Chairs:  Giovanni Apolone, Simon Oberst
Host Chair: Iwona Lugowska
 
Introduction
CCI4EU (Comprehensive Cancer Infrastructures for Europe) is a European project aiming to help Member States and Associated Countries improve or develop their existing or future Comprehensive Cancer Infrastructures (CCIs), by helping develop their research & innovation-related capacities.
 
The CCI4EU project will run over 3 years. It has already defined and created a Maturity Model with quality indicators, to map the status of CCIs throughout the EU and potentially in five Associated Countries. 9 sites have been selected for Deep Dive interventions, with 3 onsite visits to help them build their capacity in particular domains. Along with this, tailored online courses, resources and conferences are being developed to open up the capacity building to a wider audience, with the overall aim of contributing to the Horizon Europe Mission of ensuring that 90% of eligible cancer patients have access to Comprehensive Cancer Infrastructures by 2030.
 
The Conference Bringing Research Insights into Clinical Implementation was held in Warsaw, Poland, on 10 and 11 October 2024 and all interventions were recorded and are now available via these pages (to access the material, participants must register to the online course,  login to the e-ESO platform and click on the PLAY buttons inside the programme). The event gave individuals and teams from developing CCIs direction in helping them build their capacity and develop their infrastructures. The conference was intended to widen the participation of this EU grant to all Member States. The gap between research findings and clinical implementation poses a significant challenge in healthcare. Bridging this gap is essential to ensure that the latest evidence is incorporated into patient care effectively. This material is aimed at professionals involved in translational research, clinical trialists, directors of science and hospital leaders.
 
Learning Objectives
Understand the importance of capacity building in research and innovation.
Learn how to develop a research programme.
Identify the ways to bring research findings into clinical settings.
Enhance collaboration between the Stakeholders and other research centres.
Explore real-world case studies and examples of successful/unsuccessful and ongoing research.

Official language
The material is provided in English. Translations are not provided, but English subtitles can be found in the videos.
 
Registration
Registration to the course is free but mandatory. 
 
Certificate of attendance
Participants will be issued a certificate of attendance once they have completed a minimum attendance of 75% of the entire course. An online evaluation questionnaire must be completed in order to receive the certificate that will be issued by email. The evaluation questionnaire will appear in the right-hand column of the course page when participants have completed 75% of the course.
 
Organising secretariat
Sonia Bulgarelli: sbulgarelli@eso.net
Francesca Marangoni: fmarangoni@eso.net
Sarah Jennie Goldman: sgoldman@eso.net
 
10/10/2024 08:40

Welcome and introduction

Giovanni Apolone (IT) Iwona Lugowska (PL) Simon Oberst (BE)

10/10/2024 08:49

Session 1

08:50

What is capacity building in research and innovation?

Simon Oberst (BE)

10/10/2024 09:29

Session 2

09:30

What are the main pathways to bring research insights into clinical practice

Ralf Herold (NL)
09:50

Discussion


10/10/2024 10:29

Session 3

10:30

Research and innovation in the diagnostic pathway

Kjetil Taskén (NO)
10:50

AI example in Poland

Jan Poleszczuk (PL)
11:00

Discussion


10/10/2024 11:19

Session 4

11:20

Next generation design of clinical trials

Ulrik Lassen (DK)
11:40

Next generation of secondary prevention

Ugo Pastorino (IT)
11:50

Discussion


10/10/2024 12:09

Sessione 5

12:10

Federated Data Hubs

Peter Nagy (HU)
12:30

Exemplar: the work of Digicore

Gennaro Ciliberto (IT)
12:40

Discussion

11/10/2024 08:29

Session 6

08:30

Molecular diagnostics in practice

Maud Kamal (FR)
08:50

How to organise molecular tumour boards

Susana Aguilar (ES)
09:00

Discussion


11/10/2024 09:19

Session 7

09:20

Research and innovation in radiation oncology

Jozsef Lovey (NO)
09:40

Leading examples of radiotherapy clinical trials

Cai Grau (DK)
09:50

Discussion


11/10/2024 10:39

Session 8

10:40

How to develop a research programme in central/eastern Europe

Peter Nagy (HU)
11:00

Example from a central European country

Piotr Rutkowski (PL)
11:10

Discussion


11/10/2024 11:29

Session 9

11:30

How to collaborate with other research centres

Iwona Lugowska (PL)
11:50

The example of Alleanza Contro il Cancro

Paolo De Paoli (IT)
12:00

Discussion

Cai Grau profile photo
Cai Grau

Aarhus University Hospital, Danish Center for Particle Therapy, Aarhus N, DK

Gennaro Ciliberto profile photo
Gennaro Ciliberto

Istituto Nazionale Tumori Regina Elena, Scientific Directorate, Rome, IT

Giovanni Apolone profile photo
Giovanni Apolone

Fondazione IRCCS Istituto Nazionale dei Tumori, Direzione Scientifica, Milano, IT

Iwona Lugowska profile photo
Iwona Lugowska

Maria Sklodowska-Curie Institute of Oncology, Early Phase Clinical Trials, warsaw, PL

Jan Poleszczuk profile photo
Jan Poleszczuk

CliniNote, Chief Technology Officer, Lublin, PL

Jozsef Lovey profile photo
Jozsef Lovey

Oslo Universtiy Hospital, Depatment of Oncology, Oslo, NO

Kjetil Taskén profile photo
Kjetil Taskén

Oslo University Hospital, Institute for Cancer Research, Dept. of Cancer Immunology, Oslo, NO

Maud Kamal profile photo
Maud Kamal

Institut Gustave Roussy, Scientific Manager Department, Villejuif, FR

Paolo De Paoli profile photo
Paolo De Paoli

Alleanza Contro il Cancro, Alleanza Contro il Cancro, Roma, IT

Peter Nagy profile photo
Peter Nagy

National Institute of Oncology, Dept. of Molecular Immunology and Toxicology, Budapest, HU

Piotr Rutkowski profile photo
Piotr Rutkowski

Maria Sklodowska-Curie National Research Institute of Oncology, Dept. of Soft Tissue/Bone & Melanoma, Warszawa, PL

Ralf Herold profile photo
Ralf Herold

Amsterdam, NL

Simon Oberst profile photo
Simon Oberst

Organisation of European Cancer Institutes, Quality and Accreditation, Brussels, BE

Susana Aguilar profile photo
Susana Aguilar

Vall d' Hebron Institute of Oncology (VHIO), Vhioteca Dpt., Barcelona, ES

Ugo Pastorino profile photo
Ugo Pastorino

Fondazione IRCCS, Istituto Nazionale dei Tumori, Chirurgia Toracica, Milano, IT

Ulrik Lassen profile photo
Ulrik Lassen

Rigshospitalet, Dept. of Oncology 5074, Copenhagen, DK